Application 016324

Type
NDA
Sponsor
SEBELA IRELAND LTD

Application Products#

Product, Drug, Ingredient table
ProductDrugIngredientFormStrengthReference drugReference standard
001IMURANAZATHIOPRINETABLET;ORAL50MGYesYes
002IMURANAZATHIOPRINETABLET;ORAL25MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**YesNo

Source provenance: Browse the complete Orange Book source catalog · source snapshot 44.

Orange Book products#

Current product rows page 1 of 1 · 2 matching rows.

Application-product, Trade name, Ingredient table
Application-productTrade nameIngredientStrengthDosage form / routeTE codesRLD / RSApproval date
N016324-001IMURANAZATHIOPRINE50MGTABLET / ORALABRLD, RS, Approved before 1982
N016324-002IMURANAZATHIOPRINE25MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**TABLET / ORALRLD, Approved before 1982

Therapeutic equivalence codes#

Current TE-code rows page 1 of 1 · 1 matching rows.

Application-product, TE code table
Application-productTE code
N016324-001AB

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 2 of 3 · 88 observed states.

Captured, Edition, Application-product table
CapturedEditionApplication-productTrade nameStrengthDosage form / routeProduct TE source textRLD / RSApproval dateSource SHA-256
2019-12-13 00:20 UTC2019-12N016324-001IMURAN50MGTABLET / ORALABRLD, RS, Approved before 198274a2ff9319b5…
2019-12-13 00:20 UTC2019-12N016324-002IMURAN25MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**TABLET / ORALRLD, Approved before 198274a2ff9319b5…
2022-03-09 01:35 UTC2022-03N016324-001IMURAN50MGTABLET / ORALABRLD, RS, Approved before 1982bb7c543d1eb4…
2022-03-09 01:35 UTC2022-03N016324-002IMURAN25MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**TABLET / ORALRLD, Approved before 1982bb7c543d1eb4…
2021-12-28 21:50 UTC2021-12N016324-001IMURAN50MGTABLET / ORALABRLD, RS, Approved before 1982782e0a99824c…
2021-12-28 21:50 UTC2021-12N016324-002IMURAN25MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**TABLET / ORALRLD, Approved before 1982782e0a99824c…
2021-05-05 16:15 UTC · 3 captures of this ZIP2021-05N016324-001IMURAN50MGTABLET / ORALABRLD, RS, Approved before 198287673890dc5c…
2021-05-05 16:15 UTC · 3 captures of this ZIP2021-05N016324-002IMURAN25MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**TABLET / ORALRLD, Approved before 198287673890dc5c…
2021-03-12 10:30 UTC2021-03N016324-001IMURAN50MGTABLET / ORALABRLD, RS, Approved before 19825aa47cf7b7d7…
2021-03-12 10:30 UTC2021-03N016324-002IMURAN25MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**TABLET / ORALRLD, Approved before 19825aa47cf7b7d7…
2020-12-22 03:56 UTC2020-12N016324-001IMURAN50MGTABLET / ORALABRLD, RS, Approved before 19828869cabd3fbd…
2020-12-22 03:56 UTC2020-12N016324-002IMURAN25MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**TABLET / ORALRLD, Approved before 19828869cabd3fbd…
2020-11-12 02:37 UTC2020-11N016324-001IMURAN50MGTABLET / ORALABRLD, RS, Approved before 1982c0c555d07b60…
2020-11-12 02:37 UTC2020-11N016324-002IMURAN25MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**TABLET / ORALRLD, Approved before 1982c0c555d07b60…
2019-12-14 00:12 UTC2019-12N016324-001IMURAN50MGTABLET / ORALABRLD, RS, Approved before 19823f01610625f2…
2019-12-14 00:12 UTC2019-12N016324-002IMURAN25MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**TABLET / ORALRLD, Approved before 19823f01610625f2…
2019-09-15 20:21 UTC2019-09N016324-001IMURAN50MGTABLET / ORALABRLD, RS, Approved before 1982b00525d2431f…
2019-09-15 20:21 UTC2019-09N016324-002IMURAN25MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**TABLET / ORALRLD, Approved before 1982b00525d2431f…
2019-07-19 19:46 UTC2019-07N016324-001IMURAN50MGTABLET / ORALABRLD, RS, Approved before 1982ea99ee380514…
2019-07-19 19:46 UTC2019-07N016324-002IMURAN25MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**TABLET / ORALRLD, Approved before 1982ea99ee380514…
2024-03-16 18:09 UTC · 4 captures of this ZIP2024-03N016324-001IMURAN50MGTABLET / ORALABRLD, RS, Approved before 19826a51e52b5d6a…
2024-03-16 18:09 UTC · 4 captures of this ZIP2024-03N016324-002IMURAN25MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**TABLET / ORALRLD, Approved before 19826a51e52b5d6a…
2024-02-18 07:12 UTC2024-02N016324-001IMURAN50MGTABLET / ORALABRLD, RS, Approved before 19821c564ffb4f44…
2024-02-18 07:12 UTC2024-02N016324-002IMURAN25MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**TABLET / ORALRLD, Approved before 19821c564ffb4f44…
2023-12-20 04:57 UTC2023-12N016324-001IMURAN50MGTABLET / ORALABRLD, RS, Approved before 1982ea1830bbd6c7…
2023-12-20 04:57 UTC2023-12N016324-002IMURAN25MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**TABLET / ORALRLD, Approved before 1982ea1830bbd6c7…
2023-11-28 05:40 UTC · 2 captures of this ZIP2023-11N016324-001IMURAN50MGTABLET / ORALABRLD, RS, Approved before 1982a72a2bbeb626…
2023-11-28 05:40 UTC · 2 captures of this ZIP2023-11N016324-002IMURAN25MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**TABLET / ORALRLD, Approved before 1982a72a2bbeb626…
2023-10-25 00:34 UTC · 2 captures of this ZIP2023-10N016324-001IMURAN50MGTABLET / ORALABRLD, RS, Approved before 19829b2671bbb829…
2023-10-25 00:34 UTC · 2 captures of this ZIP2023-10N016324-002IMURAN25MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**TABLET / ORALRLD, Approved before 19829b2671bbb829…
2023-07-15 15:27 UTC · 2 captures of this ZIP2023-07N016324-001IMURAN50MGTABLET / ORALABRLD, RS, Approved before 1982a67488948f0b…
2023-07-15 15:27 UTC · 2 captures of this ZIP2023-07N016324-002IMURAN25MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**TABLET / ORALRLD, Approved before 1982a67488948f0b…
2023-06-13 01:57 UTC · 3 captures of this ZIP2023-06N016324-001IMURAN50MGTABLET / ORALABRLD, RS, Approved before 19823f0d92c62455…
2023-06-13 01:57 UTC · 3 captures of this ZIP2023-06N016324-002IMURAN25MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**TABLET / ORALRLD, Approved before 19823f0d92c62455…
2023-05-13 08:27 UTC2023-05N016324-001IMURAN50MGTABLET / ORALABRLD, RS, Approved before 1982053a50430f4f…
2023-05-13 08:27 UTC2023-05N016324-002IMURAN25MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**TABLET / ORALRLD, Approved before 1982053a50430f4f…
2023-01-26 05:58 UTC2023-01N016324-001IMURAN50MGTABLET / ORALABRLD, RS, Approved before 19823bdfa0b2c4d7…
2023-01-26 05:58 UTC2023-01N016324-002IMURAN25MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**TABLET / ORALRLD, Approved before 19823bdfa0b2c4d7…
2022-11-12 20:34 UTC · 5 captures of this ZIP2022-11N016324-001IMURAN50MGTABLET / ORALABRLD, RS, Approved before 19823a93d1ddd44b…
2022-11-12 20:34 UTC · 5 captures of this ZIP2022-11N016324-002IMURAN25MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**TABLET / ORALRLD, Approved before 19823a93d1ddd44b…

Observed Orange Book normalized TE history#

Normalized TE history page 1 of 2 · 44 observed states.

Captured, Edition, Application-product table
CapturedEditionApplication-productTE codeOrderSource SHA-256
2026-10-15 13:18:302026-09N016324-001AB1c2088c7a36db…
2026-09-14 22:38:342026-08N016324-001AB184e616aacf4f…
2026-08-18 06:07:402026-07N016324-001AB1caaa826d4ba7…
2026-02-19 14:30 UTC2026-02N016324-001AB1011fe1cb6892…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12N016324-001AB131067a03dcf5…
2025-08-23 18:47 UTC2025-08N016324-001AB16a471c1ec25d…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03N016324-001AB1fd3edfee7708…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02N016324-001AB1b8a1b40f171c…
2025-01-19 17:59 UTC · 7 captures of this ZIP2025-01N016324-001AB103ed91905a0d…
2024-12-13 21:23 UTC · 2 captures of this ZIP2024-12N016324-001AB12680178bc6a6…
2024-09-14 05:58 UTC · 2 captures of this ZIP2024-09N016324-001AB15bbf6a4d5a75…
2024-11-08 22:44 UTC · 3 captures of this ZIP2024-11N016324-001AB1d8e5a09893c0…
2024-10-29 15:01 UTC2024-10N016324-001AB1d06236e962d9…
2024-08-13 05:28 UTC · 3 captures of this ZIP2024-08N016324-001AB179d66fd596c7…
2024-07-13 05:37 UTC · 2 captures of this ZIP2024-07N016324-001AB1301d65b070ca…
2024-06-18 03:08 UTC · 5 captures of this ZIP2024-06N016324-001AB11e350fbaab3a…
2024-05-31 18:47 UTC2024-05N016324-001AB18072bd15b7f6…
2022-06-29 02:47 UTC · 2 captures of this ZIP2022-06N016324-001AB15c6f7cd8ea54…
2022-04-08 23:34 UTC2022-04N016324-001AB15d02ea3f76ae…
2022-04-04 05:41 UTC2022-04N016324-001AB14b0b4de00fa7…
2019-12-13 00:20 UTC2019-12N016324-001AB174a2ff9319b5…
2022-03-09 01:35 UTC2022-03N016324-001AB1bb7c543d1eb4…
2021-12-28 21:50 UTC2021-12N016324-001AB1782e0a99824c…
2021-05-05 16:15 UTC · 3 captures of this ZIP2021-05N016324-001AB187673890dc5c…
2021-03-12 10:30 UTC2021-03N016324-001AB15aa47cf7b7d7…
2020-12-22 03:56 UTC2020-12N016324-001AB18869cabd3fbd…
2020-11-12 02:37 UTC2020-11N016324-001AB1c0c555d07b60…
2019-12-14 00:12 UTC2019-12N016324-001AB13f01610625f2…
2019-09-15 20:21 UTC2019-09N016324-001AB1b00525d2431f…
2019-07-19 19:46 UTC2019-07N016324-001AB1ea99ee380514…
2024-03-16 18:09 UTC · 4 captures of this ZIP2024-03N016324-001AB16a51e52b5d6a…
2024-02-18 07:12 UTC2024-02N016324-001AB11c564ffb4f44…
2023-12-20 04:57 UTC2023-12N016324-001AB1ea1830bbd6c7…
2023-11-28 05:40 UTC · 2 captures of this ZIP2023-11N016324-001AB1a72a2bbeb626…
2023-10-25 00:34 UTC · 2 captures of this ZIP2023-10N016324-001AB19b2671bbb829…
2023-07-15 15:27 UTC · 2 captures of this ZIP2023-07N016324-001AB1a67488948f0b…
2023-06-13 01:57 UTC · 3 captures of this ZIP2023-06N016324-001AB13f0d92c62455…
2023-05-13 08:27 UTC2023-05N016324-001AB1053a50430f4f…
2023-01-26 05:58 UTC2023-01N016324-001AB13bdfa0b2c4d7…
2022-11-12 20:34 UTC · 5 captures of this ZIP2022-11N016324-001AB13a93d1ddd44b…

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
IMURANAZATHIOPRINESebela Pharmaceuticals Inc.606101a0-6244-7eff-e053-2a91aa0acadd2025-11-08Boxed warning, Warnings, Adverse reactionsExact identifier
application applno (NDA): 016324
application number: NDA016324
ndc (product): 54766-590

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

NDC Listings For This Application#

NDC listings for this application page 1 of 1 · 2 matching rows.

NDC, Name, Nonproprietary name table
NDCNameNonproprietary nameLabelerMarketing categoryStatus
54766-590IMURANazathioprineSebela Pharmaceuticals Inc.NDACurrent
65483-590IMURANazathioprinePrometheus Laboratories Inc.NDACurrent

Documents#

Document, Submission type, Date table
DocumentSubmission typeDate
79050SUPPL 2024-07-11
79034SUPPL 2024-07-10
57004SUPPL2018-12-21
56943SUPPL2018-12-21
50509SUPPL2017-11-27
12990SUPPL2014-02-11
33164SUPPL2014-02-07
12989SUPPL2011-05-26
441SUPPL2011-05-26
33163SUPPL2011-05-25
10886SUPPL2011-05-25
12988SUPPL2008-07-14
10885SUPPL2008-07-10
33162SUPPL2005-07-29
12987SUPPL2005-07-29
440SUPPL2004-06-07